Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

» Details

Insider Trades

Latest Guru Trades with IHE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
EV-to-EBIT 9.80
IHE's EV-to-EBIT is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 9.80 )
IHE' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: 9.8

PEG 1.20
IHE's PEG is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 1.20 )
IHE' s 10-Year PEG Range
Min: 0   Max: 1.2
Current: 1.2

0
1.2

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.80
IHE's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 0.80 )
IHE' s 10-Year Dividend Yield Range
Min: 0   Max: 0
Current: 0.8

Yield on cost (5-Year) 0.80
IHE's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 0.80 )
IHE' s 10-Year Yield on cost (5-Year) Range
Min: 0   Max: 0
Current: 0.8

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 4.60
IHE's Price/Tangible Book is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IHE: 4.60 )
IHE' s 10-Year Price/Tangible Book Range
Min: 0   Max: 0
Current: 4.6

Business Description

Industry: »
Compare:KH, CTFO, GBG, URGP, GPRM » details
» More Articles for IHE

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Pfizer Set to Acquire Hospira: Healthcare ETFs in Focus - ETF News And Commentary Feb 06 2015
The Zacks Analyst Blog Highlights: Actavis, Allergan, iShares U.S. Pharmaceuticals ETF, Market... Nov 19 2014
Pharma ETFs in Focus on Allergan Takeover Deal Nov 18 2014
Big Pharma Solid Q3 Earnings Put These ETFs in Focus Oct 30 2014
Drug ETFs Attractive Buys On Pullback Oct 22 2014
Some ETFs Saying a Salix Takeover Could be Afoot Oct 03 2014
Pfizer, Actavis Rumor, Inversion Turn Attention to Pharma ETFs Sep 24 2014
ETFs for Hedge Funds’ Favorite Pharma Stocks Aug 25 2014
The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals... Aug 25 2014
Pharma ETF Investing 101 Aug 21 2014
Pharma ETFs in Focus on String of Earnings Beat Jul 30 2014
Sector Performance Update - First Half 2014 Jul 22 2014
Johnson & Johnson, Goldman Sachs Pushing These ETFs Upward Jul 15 2014
Big Pharma Looks For New Models Jun 10 2014
How Will Pfizer Treat These Healthcare ETFs? May 06 2014
Johnson & Johnson: Why Top Funds Are Buying May 01 2014
Merck (MRK) Earnings Beat Puts Healthcare ETFs in Focus Apr 30 2014
Pharma ETFs: A Safe Haven from the Biotech Stock Slump? Apr 28 2014
Investors Flee Once Hot Health Care ETFs Apr 28 2014
Pharma ETFs: A Safe Haven from the Biotech Slump? Apr 25 2014
Pharmaceutical ETFs Surge On M&A Activity Apr 23 2014
Pharma ETFs: A Better Healthcare Investment? Apr 23 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK